Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00178581 · ClinicalTrials.gov registry record · Phase 1
Enteral Glutamine Supplementation for the Patient With Major Torso Trauma
A Phase 1 study, sponsored by The University of Texas Health Science Center, Houston.
- Terminated
- Registry status
- Phase 1
- Development phase
- 20
- Enrollment target
NCT00178581 is a Phase 1 study that was terminated before completion, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 20 participants.
The verdict
NCT00178581, a Phase 1 study, was terminated before completion, sponsored by The University of Texas Health Science Center, Houston.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 20 participants
- Enrollment target
Study Summary
Glutamine is considered a conditionally essential amino acid during critical illness. After severe trauma, glutamine supplementation into the gastrointestinal tract may help maintain bowel function. We hypothesize that for the major torso trauma patient, high dose glutamine given enterally during resuscitation from shock and continued during enteral nutrition support is absorbed, available systemically and preserves gut integrity.
Interventions
- DRUG Glutamine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2005-06 |
| Est. Completion | 2006-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00178581
The ClinicalTrials.gov registry entry for NCT00178581 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Glutamine is the first listed.
NCT00178581 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00178581 about?
NCT00178581 is a clinical study titled "Enteral Glutamine Supplementation for the Patient With Major Torso Trauma". Glutamine is considered a conditionally essential amino acid during critical illness. After severe trauma, glutamine supplementation into the gastrointestinal tract may help maintain bowel function. We hypothesize that for the major torso trauma patient, high dose glutamine given enterally during re...
What is the current status of trial NCT00178581?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2005-06. Estimated completion is 2006-09.
What interventions are being tested in trial NCT00178581?
The interventions under investigation include: Glutamine (DRUG).
Who is sponsoring clinical trial NCT00178581?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.